Storia in 2 fonti

Societe General, Prudential, others buy 3% stake in Anthem Biosciences for ₹1,275 cr

Global investors, led by Societe Generale and Prudential, acquire 3% stake in Anthem Biosciences for ₹1,275 crore.

Raccontata da

economictimes.indiatimes.com

thehindubusinessline.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo1 mese fa

Societe General, Prudential, others buy 3% stake in Anthem Biosciences for ₹1,275 cr

Societe Generale, Prudential, Ghisallo Capital e altri investitori globali hanno acquisito il 3% di Anthem Biosciences per ₹1,275 crore. L'operazione riflette crescente interesse istituzionale verso India quale hub per biotech manufacturing e outsourcing R&D pharma.

originale

economictimes.indiatimes.com1 mese fa

Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 cr

Societe Generale, Prudential acquired 3% of Anthem Biosciences for Rs 1,275 crore from promoter Ganesh. The deal signals institutional confidence in India's CRDMO capacity, relevant to managers tracking outsourcing consolidation in supply chains.

Timeline cronologica

venerdì 19 giugno 2026·economictimes.indiatimes.com
Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 cr
Global investors including Societe Generale and Prudential Hong Kong, alongside Indian mutual funds and insurance companies, have bought a 3 percent stake in Anthem Biosciences.…
venerdì 19 giugno 2026·thehindubusinessline.com
Societe General, Prudential, others buy 3% stake in Anthem Biosciences for ₹1,275 cr
Global investors, led by Societe Generale and Prudential, acquire 3% stake in Anthem Biosciences for ₹1,275 crore.